American Society of Clinical Oncology

SHERPA: White

People

  1. Voss
    Voss
  2. Motzer
    Motzer
  3. Chaim
    Chaim
  4. Chen
    Chen
  5. Feldman
    Feldman
  6. Berger
    Berger
  7. Bhanot
    Bhanot
  8. Carlo
    Carlo
  9. Cheng
    Cheng
  10. Coleman
    Coleman

Groups

  1. Department of Medicine (8)
  2. Genitourinary Oncology Service (8)
  3. Solid Tumor Oncology Division (8)
  4. Biostatistics Service (2)
  5. Body Imaging Service (2)
  6. Epidemiology and Biostatistics (2)
  7. GSK Faculty (2)
  8. Human Oncology and Pathogenesis Program (2)
  9. Radiology, Department of (2)
  10. Computational Biology Program Faculty (1)
Search Within
  1. "Martin Voss"
  2. "2016"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (1)
Groups
  1. Department of Medicine (8)
  2. Genitourinary Oncology Service (8)
  3. Solid Tumor Oncology Division (8)
  4. Biostatistics Service (2)
  5. Body Imaging Service (2)
  6. Epidemiology and Biostatistics (2)

More Groups

People
  1. Martin Voss (8)
  2. Robert Motzer (6)
  3. James Hsieh (5)
  4. Yingbei Chen (4)
  5. Chung-Han Lee (2)
  6. Darren Feldman (2)

More People

Years
  1. 2016 (8)
Publications
  1. Journal of Clinical Oncology (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Baseline lactate dehydrogenase (LDH) and overall survival (OS) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with everolimus (EVE) versus sunitinib (SUN): Predictive biomarker analysis from the RECORD-3 trial
    Meeting Abstract

    Voss, M. H.; Chen, D.; Marker, M.; Knox, J.; Hsieh, J.; Voi, M.; Motzer, R. J.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS), alone and in combination with everolimus (E) in patients (pts) with renal cell cancer (RCC)
    Meeting Abstract

    Meric-Bernstam, F.; Tannir, N. M.; Mier, J. W.; DeMichele, A.; Telli, M. L.; Fan, A. C.; Munster, P. N.; Carvajal, R. D.; Orford, K. W.; Bennett, M. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Medullary renal cell carcinoma (RCC): Genomics and treatment outcomes
    Meeting Abstract

    Carlo, M. I.; Chen, Y.; Chaim, J.; Coskey, D. T.; Woo, K.; Hsieh, J.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.; Lee, C. H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase II trial and correlative genomic analysis of everolimus plus bevacizumab in advanced non-clear cell renal cell carcinoma
    Journal Article

    Voss, M. H.; Molina, A. M.; Chen, Y. B.; Woo, K. M.; Chaim, J. L.; Coskey, D. T.; Redzematovic, A.; Wang, P.; Lee, W.; Selcuklu, S. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The immune landscape of renal cell carcinoma and its association with intratumoral clonality
    Meeting Abstract

    Winer, A. G.; Senbabaoglu, Y.; Gejman, R.; Ostrovnaya, I.; Kaffenberger, S. D.; Voss, M. H.; Coleman, J. A.; Russo, P.; Hsieh, J.; Sander, C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Mutation burden and tumor neoantigens in RCC patients (pts) treated with nivolumab
    Meeting Abstract

    Voss, M. H.; Hellmann, M. D.; Chen, Y.; Gold, T. M.; Lambert, C. R.; VanAllen, E.; Choueiri, T. K.; Charen, A. S.; Motzer, R. J.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Differential overall survival (OS) results in RECORD-3 study based on three distinct mRCC molecular subgroups classified by BAP1 and/or PBRM1 mutations
    Meeting Abstract

    Hsieh, J.; Chen, D.; Wang, P.; Chen, Y.; Marker, M.; Patel, P.; Chevinsky, M.; Bhanot, U.; Pinciroli, P.; Berger, M. F.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Integrated genomic correlates of response to PD-1 inhibitor nivolumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    de Velasco, G.; Miao, D.; Shukla, S.; Voss, M. H.; Wu, C.; Murray, B.; Meyerson, M.; Signoretti, S.; Motzer, R. J.; Van Allen, E. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save